COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.217
https://www.valueinhealthjournal.com/article/S1098-3015(13)02122-0/fulltext
Title :
COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02122-0&doi=10.1016/j.jval.2013.08.217
First page :
A359
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
204